GlassScriptPhysician profile
Ronda I Oconnell
NPI 1902152911
$961.73
in general payments reported to CMS, 2019-2025
18 companies · $242 in 2025
The $242 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $99.23 · 2023: $172 · 2024: $448 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $163.93 | 2022-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $138.25 | 2022-2025 | Airsupra, Breztri |
| Boston Scientific Corporation | $101.46 | 2024 | Wavewriter Alpha Prime 16 |
| Novo Nordisk INC | $93.95 | 2022-2025 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $65.46 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $55.12 | 2024-2025 | Veozah |
| Amgen INC. | $51.38 | 2023-2025 | Evenity, Krystexxa, Prolia |
| Glaxosmithkline, LLC. | $47.65 | 2023-2025 | Shingrix, Arexvy |
| Abbvie INC. | $34.86 | 2022-2024 | |
| Currax Pharmaceuticals LLC | $31.85 | 2023 | Contrave |
| Pfizer INC. | $29.44 | 2023 | |
| Sumitomo Pharma America, INC. | $26.54 | 2024 | Gemtesa |
| Abbott Laboratories | $24.53 | 2024 | Freestyle Libre 3 |
| Dexcom, INC. | $22.88 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $22.86 | 2024 | Capvaxive, Gardasil 9, Gardasil |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.66 | 2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $17.24 | 2022 | |
| Phathom Pharmaceuticals, INC. | $16.67 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronda Oconnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.